USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
10 Jan 2018 | Asia Pacific | Market Research
APAC Biosimilar Market, Forecast 2025
Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth
Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Ko...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Jun 2017 | Asia Pacific | Market Research
Growth Opportunities in the APAC IVD Market, Forecast to 2021
Digital Pathology and Laboratory Automation are Two Strategic Themes Driving the Growth of the IVD Market
The study aims to analyze and forecast the Asia Pacific (APAC) in-vitro diagnostics (IVD) market outlook and technology trends for 2016. Research Scope: • Key trends and opportunities in the IVD market, which has been segmented into 8 major divisions: o Immunochemistry o Self-monitoring Blood Glucose (SMBG) Meter o Hematology o Point-of-care...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Mar 2017 | Asia Pacific | Market Research
APAC Molecular Diagnostics Market, Forecast to 2021
Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth
The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identif...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Jul 2016 | Asia Pacific | Market Research
Analysis of the APAC Health Information Exchange Market
This research service analyzes the health information exchange (HIE) market in Asia-Pacific. Driven primarily by governments, the region is embarking on the next phase of healthcare IT transformation, investing in decentralizing patient information by enabling data exchange among established electronic medical record (EMR) and electronic health rec...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 May 2016 | Asia Pacific | Market Outlook
Asia-Pacific Telehealth Market Outlook, Forecast to 2020
Shifting Cost and Consumer Trends to Support Innovative Delivery Models Driven by mHealth, Remote Patient Monitoring and Telemedicine
Healthcare industry challenges including aging populations, rising incidence of chronic diseases, and the need to manage care costs better are necessitating the adoption of innovative care delivery models. While healthcare providers and consumers are displaying a perceivable behavior shift in the way they interact with health technologies, vendors ...
$4,950.00
Special Price $3,712.50 save 25 %
-
06 May 2016 | Asia Pacific | Market Research
Global Generic Pharmaceuticals Market, Forecast to 2020
Market Participants Target High Value-added Branded Generics and Biosimilars Segments
The key objectives of this research service are to gain an in-depth knowledge of the major markets and therapeutic areas and organizations presenting significant growth opportunities for generics, to understand the impact of regulation on the market, and to outline the industry consolidation trends that will continue shaping the future of generics....
$4,950.00
Special Price $3,712.50 save 25 %
-
18 Apr 2016 | Asia Pacific | Market Outlook
Asia-Pacific Healthcare Outlook, 2016
Clinical Wearables, Regenerative Medicines and Biosimilars Set for Strong Growth
Demand for healthcare services will continue to grow in Asia-Pacific (APAC) under the influence of demographic and epidemiological transitions impacting the entire region. APAC governments which shoulder the largest burden of paying for healthcare services will take decisive steps to innovate their healthcare systems in order to face future challen...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Nov 2015 | Asia Pacific | Market Research
Asia-Pacific Point-of-Care Testing Market
Trends, Challenges, and Best Practices for Stakeholders
Asia-Pacific (APAC) point-of-care testing (POCT) market was worth $2.80 billion in 2014. In hospitals, POC is used more in emergency rooms (ERs), operation theatres (OTs), recovery rooms (RRs), cath labs, and intensive care units (ICU). The rental model in which the cost of the device is borne by the manufacturer while the profit is shared by the h...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Sep 2015 | Asia Pacific | Market Research
End-User Perspectives on the SEA RIS/ PACS Market
Next-generation Imaging IT Needs Will Focus on Interoperability
Picture archiving communication systems (PACS) were a real game changer 3 decades ago when, in combination with radiology information systems (RIS), they enabled rapid digitalization of medical imaging data. Today, Southeast Asia again stands at the brink of transformation as RIS PACS enter their second or third generation of deployment. In an effo...
$4,950.00
Special Price $3,712.50 save 25 %
-
02 Sep 2015 | Asia Pacific | Market Research
Analysis of the Global Human Albumin Market and Product Pipeline
Emerging Economies and Use of Human Albumin as an Excipient Present New Growth Opportunities
The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...
$4,950.00
Special Price $3,712.50 save 25 %
